SCHEMBL531567

SCHEMBL531567

CCCCN(CCCCCO)C(N)=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.48
CA1 P00915 5/20 0.48
CA9 Q16790 5/20 0.48
CA2 P00918 3/20 0.48
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
HSD17B10 Q99714 1/20 0.46
TSHR P16473 1/20 0.46
ALDH2 P05091 1/20 0.45
MGLL Q99685 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP8 P22894 1/20 0.34
DNM1 Q05193 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28929084 0.88 ALDH1A1 (0.48) CA12CA1CA9CA2ALDH1A1
SCHEMBL5695010 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL27866693 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL5695101 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL9665534 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL635408 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL11387308 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL17956778 0.87 CA12 (0.61) CA12CA1CA9CA2ALDH1A1
SCHEMBL15420 0.87 ALDH1A1 (0.56) CA12CA1CA9CA2ALDH1A1
SCHEMBL28483475 0.85 ALDH1A1 (0.54) CA12CA1CA9CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1610126-B1 A system for determining the electrical potential across a membrane UNIV CALIFORNIA (US) 2014-04-30 EP disclosed
EP-1409456-B1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 2012-02-08 EP disclosed
EP-0977035-B2 A system for determining the electrical potential across a membrane UNIV CALIFORNIA (US) 2010-07-21 EP disclosed
US-7687282-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-30 US disclosed
US-7173130-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-06 US disclosed
US-20070026384-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-02-01 US disclosed
US-7118899-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-10 US disclosed
US-7115401-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-10-03 US disclosed
US-7087416-B2 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-08-08 US disclosed
EP-1610126-A1 A system for determining the electrical potential across a membrane THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-28 EP disclosed
US-20030129670-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-07-10 US disclosed
US-20020164577-A1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-11-07 US disclosed
US-20020137201-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-09-26 US disclosed
US-6342379-B1 Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-01-29 US disclosed
WO-2001042211-A2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-06-14 WO disclosed
US-6107066-A Detection of transmembrane potentials by optical methods THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-08-22 US disclosed
EP-0977035-A2 A system for determining the electrical potential across a membrane REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2000-02-02 EP disclosed
EP-0834074-B1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS UNIV CALIFORNIA (US) 1999-11-03 EP disclosed
EP-0834074-A1 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-04-08 EP disclosed
WO-1996041166-A2 DETECTION OF TRANSMEMBRANE POTENTIALS BY OPTICAL METHODS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070026384-A1 Detection of transmembrane potentials by optical methods MBOAT1, TRPM4, NME4 CA12 909/4885CA1 1244/4885CA9 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.